As has become all too characteristic of arguments from liberal skeptics of the Democrats’ health care plan, analyses of the recent increase in share prices of major publicly-traded health care stocks have been misleading.
As we and other analysts have documented, share prices have reacted strongly and unambiguously to news that a public option might or might not be part of the Democrats’ health care reform plans. This is in line with a report issued in November from Goldman Sachs, which estimated that a health care plan passed with a robust public option — their so called “bear” case — should result in a 36 percent drop in the prices of publicly-traded health insurance stocks:
Read complete analysis at FiveThirtyEight –>
Join the conversation about this story »
See Also:
- 7 Reasons Why A Christmas Eve Vote On Health Care Would Be The Worst Gift Ever
- Why The Supreme Court Should Strike Down Health Care Reform’s Individual Mandate
- Democratic Senators Say They Have 60 Votes For Health Care Reform